Studien/Forschung > Forschung


Wissenschaftliche Aktivitäten des HTZ Ruhr-Universität

1: Gambichler T, Plura I, Schmid-Wendtner M, Valavanis K, Kulichova D,
Stücker M, Pljakic A, Berking C, Maier T. High-definition optical coherence tomography
of melanocytic skin lesions. J Biophotonics. 2014 Sep 18;9999(9999). doi:
10.1002/jbio.201400085. [Epub ahead of print] PubMed PMID: 25237005.

2: Gambichler T, Schmid-Wendtner MH, Plura I, Kampilafkos P, Stücker M,
Berking C, Maier T. A multicentre pilot study investigating high-definition optical
coherence tomography in the differentiation of cutaneous melanoma and
melanocytic naevi. J Eur Acad Dermatol Venereol. 2015 Mar;29(3):537-41. doi:
10.1111/jdv.12621. Epub 2014 Jul 30. PubMed PMID: 25073788.

3: Gambichler T, Kempka J, Kampilafkos P, Bechara FG, Altmeyer P, Stücker M.
Clinicopathological characteristics of 270 patients with lentigo maligna and
lentigo maligna melanoma: data from a German skin cancer centre. Br J
2014 Dec;171(6):1605-7. doi: 10.1111/bjd.13204. Epub 2014 Oct 22. PubMed
PMID: 24958545.

4: Scola N, Segert HM, Stücker M, Altmeyer P, Gambichler T, Kreuter A. Ki-67
may be useful in differentiating between keratoacanthoma and cutaneous squamous
cell carcinoma. Clin Exp Dermatol. 2014 Mar;39(2):216-8. doi: 10.1111/ced.12219.
Epub 2013 Nov 20. PubMed PMID: 24524559.

5: Gambichler T, Plura I, Kampilafkos P, Valavanis K, Sand M, Bechara FG,
Stücker M. Histopathological correlates of basal cell carcinoma in the slice and en
face imaging modes of high-definition optical coherence tomography. Br J
2014 Jun;170(6):1358-61. doi: 10.1111/bjd.12797. PubMed PMID: 24359160.

6: Gambichler T, Scholl L, Stücker M, Bechara FG, Hoffmann K, Altmeyer P,
Othlinghaus N. Clinical characteristics and survival data of melanoma
patients with nevus cell aggregates within sentinel lymph nodes. Am J Clin Pathol.
2013 May;139(5):566-73. doi: 10.1309/AJCPG83CMAVFBWLC. PubMed PMID: 23596107.

7: Gambichler T, Sand M, Skrygan M. Loss of 5-hydroxymethylcytosine and
ten-eleven translocation 2 protein expression in malignant melanoma.
Melanoma Res. 2013 Jun;23(3):218-20. doi: 10.1097/CMR.0b013e32835f9bd4. PubMed PMID:

8: Gambichler T, Scholl L. Sentinel lymph node status is the strongest
independent predictor for disease free and overall survival in patients with
thick melanoma. J Eur Acad Dermatol Venereol. 2013 Nov;27(11):1454-6. doi:
10.1111/jdv.12087. Epub 2012 Dec 31. PubMed PMID: 23279361.

9: Sand M, Skrygan M, Sand D, Georgas D, Gambichler T, Hahn SA, Altmeyer P,
Bechara FG. Comparative microarray analysis of microRNA expression profiles
in primary cutaneous malignant melanoma, cutaneous malignant melanoma
metastases, and benign melanocytic nevi. Cell Tissue Res. 2013 Jan;351(1):85-98. doi:
10.1007/s00441-012-1514-5. Epub 2012 Oct 31. PubMed PMID: 23111773.

10: Gambichler T, Scola N, Bechara FG. Significantly decreased
methylthioadenosine phosphorylase expression in malignant melanoma. Am J
Dermatopathol. 2012 Oct;34(7):777-9. PubMed PMID: 23000879.

11: Gambichler T, Bindsteiner M, Höxtermann S, Kreuter A. Serum
25-hydroxyvitamin D serum levels in a large German cohort of patients with melanoma. Br J
Dermatol. 2013 Mar;168(3):625-8. doi: 10.1111/j.1365-2133.2012.11212.x. Epub 2012 Oct
5. PubMed PMID: 22880705.

12: Scola N, Gambichler T, Saklaoui H, Bechara FG, Georgas D, Stücker M,
Gläser R, Kreuter A. The expression of antimicrobial peptides is significantly
altered in cutaneous squamous cell carcinoma and precursor lesions. Br J Dermatol.
Sep;167(3):591-7. doi: 10.1111/j.1365-2133.2012.11110.x. PubMed PMID:

13: Sand M, Skrygan M, Georgas D, Sand D, Gambichler T, Altmeyer P, Bechara
FG. The miRNA machinery in primary cutaneous malignant melanoma, cutaneous
malignant melanoma metastases and benign melanocytic nevi. Cell Tissue Res. 2012
Oct;350(1):119-26. doi: 10.1007/s00441-012-1446-0. Epub 2012 Jun 17. PubMed

14: Gambichler T, Pantelaki I, Othlinghaus N, Moritz RK, Stricker I, Skrygan
M. Deep intronic point mutations of the KIT gene in a female patient with
cutaneous clear cell sarcoma and her family. Cancer Genet. 2012 Apr;205(4):182-5. doi:
10.1016/j.cancergen.2012.02.001. PubMed PMID: 22559980.

15: Sand M, Skrygan M, Sand D, Georgas D, Hahn SA, Gambichler T, Altmeyer P,
Bechara FG. Expression of microRNAs in basal cell carcinoma. Br J Dermatol.
2012 Oct;167(4):847-55. doi: 10.1111/j.1365-2133.2012.11022.x. Epub 2012 Aug 20.
PubMed PMID: 22540308.

16: Sand M, Skrygan M, Georgas D, Arenz C, Gambichler T, Sand D, Altmeyer P,
Bechara FG. Expression levels of the microRNA maturing microprocessor
complex component DGCR8 and the RNA-induced silencing complex (RISC) components
argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin
cancer. Mol Carcinog. 2012 Nov;51(11):916-22. doi: 10.1002/mc.20861. Epub 2011 Oct 24.
PubMed PMID: 22025453.

17: Sand M, Gambichler T, Sand D, Altmeyer P, Stuecker M, Bechara FG.
Immunohistochemical expression patterns of the microRNA-processing enzyme
Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic
melanocytic nevi. Eur J Dermatol. 2011 Jan-Feb;21(1):18-21. doi:
10.1684/ejd.2011.1210. PubMed PMID: 21262599.

18: Gambichler T, Kobus S, Kreuter A, Wieland U, Stücker M. Primary merkel
cell carcinoma clinically presenting as deep oedematous mass of the groin. Eur J
Med Res. 2010 Jun 28;15(6):274-6. PubMed PMID: 20696637; PubMed Central PMCID:

19: Sand M, Gambichler T, Skrygan M, Sand D, Scola N, Altmeyer P, Bechara
FG. Expression levels of the microRNA processing enzymes Drosha and dicer in
epithelial skin cancer. Cancer Invest. 2010 Jul;28(6):649-53. doi:
10.3109/07357901003630918. PubMed PMID: 20210522.

20: Kreuter A, Potthoff A, Brockmeyer NH, Gambichler T, Swoboda J, Stücker
M, Schmitt M, Pfister H, Wieland U; German Competence Network HIV/AIDS. Anal
carcinoma in human immunodeficiency virus-positive men: results of a
study from Germany. Br J Dermatol. 2010 Jun;162(6):1269-77. doi:
10.1111/j.1365-2133.2010.09712.x. Epub 2010 Feb 22. PubMed PMID: 20184584.